Is the Chinese Shar-Pei a high-risk breed for hip dysplasia?
It's not among the very highest-rate breeds, but it isn't risk-free either, and its narrow genetic history is a plausible contributing factor.
Quick answer
Is the Chinese Shar-Pei a high-risk breed for hip dysplasia?
It's not among the very highest-rate breeds, but it isn't risk-free either, and its narrow genetic history is a plausible contributing factor.
Size alone doesn't predict which breeds top the hip dysplasia charts, and that surprises most owners the first time they see the data.

Prospective buyers comparing breeds by health risk, and current owners wanting to understand where their Shar-Pei's screening results actually fit in the bigger picture.
This guide is not medical advice. If your dog shows pain, sudden behavior change, or worsening symptoms, consult a licensed veterinarian.
Some links may be affiliate links. We may earn a commission at no extra cost to you. We only suggest products we believe are helpful for dog owners.
We research and check what we publish, but we do not warrant that any figure, date, price, or statement is accurate, complete, or current, and we accept no liability for any loss, cost, injury, or other harm arising from the use of this site. Use it as one reference among several. You remain responsible for your own decisions and for your dog's care - confirm anything that matters with a licensed veterinarian or another qualified professional before you act on it. Full disclaimer.
Hip dysplasia prevalence varies by specific breed genetics rather than simply by adult body size, meaning medium breeds like the Chinese Shar-Pei and even small breeds like the French Bulldog can show meaningful rates despite not being classic giant breeds. Understanding where a breed sits in published data helps buyers ask the right screening questions before purchasing a puppy.
The Chinese Shar-Pei doesn't top breed-wide hip dysplasia rankings, but published data shows the condition isn't confined to large and giant breeds either, making screening relevant for buyers regardless of the specific breed's typical size category.
The Shar-Pei's dramatic population bottleneck during its near-extinction in the mid-20th century narrowed the breed's genetic diversity, a pattern that in dogs generally can concentrate a range of inherited conditions, including joint laxity, regardless of the breed's typical adult size.
Rapid growth during puppyhood, excess weight, and high-impact activity all interact with any inherited joint looseness to determine how early and how severely dysplasia symptoms actually appear in an individual dog.
Discuss hip screening options at your puppy's early wellness visits, and follow up promptly if your vet notes any gait abnormality, reluctance to jump, or asymmetry during a physical exam, regardless of what breed-wide statistics might suggest about overall risk.
Start here: Chinese Shar-Pei Most Common Genetic Disorders: Screening
See all Chinese Shar PEI health problems, which breeds are prone to hip dysplasia prevalence, or the full Chinese Shar PEI breed guide for temperament, exercise needs and ownership costs.
Meaningful screening data, whether OFA or PennHIP, typically requires the dog to reach a certain age, four months for PennHIP or roughly two years for a final OFA certification, so buyers researching parent dogs should expect breeders of proven, mature dogs to have this information ready.
Success looks like an informed purchase decision based on actual documented screening results rather than breed reputation alone, paired with your own puppy's individual evaluation as it grows into adulthood.
Hip dysplasia is fundamentally about how tightly the ball of the femur fits into the hip socket, a trait controlled by a combination of many genes plus growth-rate factors during puppyhood, not simply by adult body weight. That's how a small breed like the French Bulldog ends up with meaningfully high dysplasia rates on OFA's public database despite weighing a fraction of a Labrador, and it's why a medium, densely built breed like the Chinese Shar-Pei shouldn't be assumed low-risk purely because it isn't a 100-pound dog. What matters more is the specific breed's genetic background, and the Shar-Pei's history includes a severe population bottleneck decades ago that concentrated a limited gene pool, a scenario that in dogs generally tends to raise the prevalence of a wide range of inherited orthopedic and immune conditions, hip looseness among them.
For anyone shopping for a Shar-Pei puppy, the practical takeaway from breed-wide prevalence data is less about a single percentage and more about a screening habit: ask whether the puppy's parents have documented hip evaluations, whether through OFA scoring or PennHIP analysis, rather than taking a breeder's word that "the line is fine." A breeder who can produce actual paperwork, ideally showing multiple generations of screened, unaffected dogs, is doing meaningfully more to reduce your puppy's individual risk than breed-wide statistics alone can tell you. Breed averages describe a population; they don't describe the specific puppy in front of you, and that gap is exactly what parent screening closes.

If you think your Chinese has hip dysplasia prevalence, the plan is three steps: write down what you have seen and when it started, book a veterinary appointment rather than waiting for the next flare, and take video of the behaviour or symptom before you go — the thing you are worried about rarely happens in the consulting room. Screening in the parents covers skin fold dermatitis, entropion, familial shar-pei fever.
What the vet visit should produce is a diagnosis and a written plan, not just reassurance: what is being ruled out, what the monitoring interval is, and which signs mean you come back sooner. Ask what the treatment costs across a year rather than per visit, because that is the number that decides whether you are managing this condition or reacting to it.
Between appointments, keep a short log — dates, what you saw, what changed. It is the single most useful thing an owner brings to a follow-up, and for hip dysplasia prevalence it is often what separates a clear pattern from a guess.
Otis's future owner, shopping for a Shar-Pei puppy near Madison, Wisconsin, almost skipped asking about hip screening entirely, assuming a medium breed like this one wasn't really at risk. The breeder, to her credit, volunteered the information anyway: Otis's mother had a fair OFA score, borderline rather than excellent. Rather than walking away, the buyer asked to see the grandparents' results too, both of which were good. She proceeded with the purchase, and had Otis's own hips evaluated at two years old, coming back clear. Having the full picture rather than just one generation's score gave her real confidence in the decision.
Key takeaway: A single borderline score doesn't tell the whole story, and asking for multiple generations of screening data turned an uncertain moment into an informed decision rather than a guess.
No, that's a common misconception. Dysplasia rates vary by specific breed genetics and growth patterns, not simply by adult body size, and even small breeds like the French Bulldog show meaningful rates in OFA data.
It isn't among the handful of breeds with the very highest reported rates, but it isn't negligible either, and the breed's narrow genetic founder history is a plausible contributor to its documented cases.
The Orthopedic Foundation for Animals evaluates hip X-rays submitted by vets and assigns a rating from excellent down through dysplastic, creating a public, breed-searchable database that buyers can check before purchasing a puppy.
PennHIP measures actual joint laxity through a specialized stress radiograph technique and can be performed as early as sixteen weeks, while traditional OFA evaluation typically waits until the dog is closer to two years old for a final certified score.
Yes, always. Ask specifically whether both parents have documented OFA or PennHIP results, and ideally look for a pattern of screened, healthy hips across multiple generations rather than just the two immediate parents.
Yes, screening reduces risk but doesn't eliminate it entirely, since the condition involves multiple genes and environmental growth factors. Screening improves the odds meaningfully; it isn't an absolute guarantee.
The Chinese Shar-Pei nearly went extinct in the mid-20th century, and the small number of surviving dogs used to rebuild the breed narrowed its genetic diversity, a pattern that in dog breeds generally tends to concentrate inherited conditions, orthopedic issues included.
It's not among the very highest-rate breeds, but it isn't risk-free either, and its narrow genetic history is a plausible contributing factor.
Ask for documented OFA or PennHIP results for both parents, ideally showing a multi-generation pattern of screened, healthy hips.
No, small breeds like the French Bulldog show meaningful rates in OFA data, proving size alone doesn't predict risk.
That cost falls on the breeder for the parent dogs, but ask to see the actual certificates rather than assuming; reputable breeders will have this readily available.
Yes, OFA maintains a public, searchable database by breed that any prospective buyer can review before choosing a breeder.
A one-page prep sheet for this condition: the signs, the questions to ask, what to get priced. Unlocks here.
You get: Vet visit prep sheet
No spam. One-click unsubscribe. See our privacy policy.
Preview page 1 before you decide.





